Skip to main content
PMC home page
Brain Pathology logoLink to Brain Pathology
. 2006 Apr 5;14(3):265–274. doi: 10.1111/j.1750-3639.2004.tb00063.x

Interferon‐γ Expression in Periventricular Leukomalacia in the Human Brain

Rebecca D Folkerth 1,2,✉, Rachael J Keefe 3, Robin L Haynes 3, Felicia L Trachtenberg 4, Joseph J Volpe 3, Hannah C Kinney 1,3
PMCID: PMC8095901  PMID: 15446581

Abstract

Periventricular leukomalacia (PVL), the major lesion underlying cerebral palsy in survivors of prematurity, is characterized by focal periventricular necrosis and diffuse gliosis of immature cerebral white matter. Causal roles have been ascribed to hypoxiaischemia and maternal‐fetal infection, leading to cytokine responses, inflammation, and oligodendrocyte cell death. Because interferon‐γ (IFN‐γ) is directly toxic to immature oligodendrocytes, we tested the hypothesis that it is expressed in PVL (N=13) compared to age‐adjusted controls (N=31) using immunocytochemistry. In PVL, IFN‐γ immunopositive macrophages were clustered in necrotic foci, and IFN‐γ immunopositive reactive astrocytes were present throughout the surrounding white matter (WM). The difference in the number of IFN‐y immunopositive glial cells/high power field (IFN‐γ score, Grades 0–3) between PVL cases (age‐adjusted mean 2.59 ±0.25) and controls (age‐adjusted mean 1.39±0.16) was significant (p<0.001). In the gliotic WM, the IFN‐γ score correlated with markers for lipid peroxidation, but not nitrative stress. A subset of premyelinating (O4+) oligodendrocytes expressed IFN‐γ receptors in PVL and control cases, indicating that these cells are vulnerable to IFN‐γ toxicity via receptor‐mediated interactions. In PVL, IFN‐γ produced by macrophages and reactive astrocytes may play a role in cytokine‐induced toxicity to premyelinating oligodendrocytes as part of a cytokine response stimulated by ischemia and/or infection.

Full Text

The Full Text of this article is available as a PDF (419.7 KB).

REFERENCES

  • 1. Agresti C, Bernardo A, Del Russo N, Marziali G, Battistini A, Aloisi F, Levi G, Coccia EM (1998) Synergistic stimulation of MHC class I and IRF‐1 gene expression by IFN‐gamma and TNF‐alpha in oligodendrocytes. Eur J Neurosci 10: 2975–2983. [DOI] [PubMed] [Google Scholar]
  • 2. Back SA, Luo NL, Borenstein NS, Levine JM, Volpe JJ, Kinney HC (2001) Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. J Neurosci 21: 1302–1312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Back SA, Han BH, Luo NL, Chricton CA, Xanthoudakis S, Tam J, Arvin KL, Holtzman DM (2002) Selective vulnerability of late oligodendrocyte progenitors to hypoxia‐ischemia. J Neurosci 22: 455–463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Back SA, Luo NL, Borenstein NS, Volpe JJ, Kinney HC (2002) Arrested oligodendrocyte lineage progression during human cerebral white matter development: dissociation between the timing of progenitor differentiation and myelinogenesis. J Neuropathol Exp Neurol 61:197–211. [DOI] [PubMed] [Google Scholar]
  • 5. Baerwald KD, Popko B (1998) Developing and mature oligodendrocytes respond differently to the immune cytokine interferon‐gamma. J Neurosci Res 52:230–239. [DOI] [PubMed] [Google Scholar]
  • 6. Balasingam V, Tejada‐Berges T, Wright E, Bouckova R, Yong VW (1994) Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines. J Neurosci 14: 846–856. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Benveniste EN, Benos DJ (1995) TNF‐alpha‐ and IFN‐gamma‐mediated signal transduction pathways: effects on glial cell gene expression and function. Faseb J 9: 1577–1584. [DOI] [PubMed] [Google Scholar]
  • 8. Benveniste EN, Tang LP, Law RM (1995) Differential regulation of astrocyte TNF‐alpha expression by the cytokines TGF‐beta, IL‐6 and IL‐10. Int J Dev Neurosci 13: 341–349. [DOI] [PubMed] [Google Scholar]
  • 9. Bhat NR, Zhang P, Bhat AN (1999) Cytokine induction of inducible nitric oxide synthase in an oligodendrocyte cell line: role of p38 mitogen‐activated protein kinase activation. J Neurochem 72:472–478. [DOI] [PubMed] [Google Scholar]
  • 10. Bolanos JP, Almeida A, Stewart V, Peuchen S, Land JM, Clark JB, Heales SJ (1997) Nitric oxidemediated mitochondrial damage in the brain: mechanisms and implications for neurodegenerative diseases. J Neurochem 68: 2227–2240. [DOI] [PubMed] [Google Scholar]
  • 11. Cofano F, Landolfo S, Appella E, Ullrich SJ (1989) Analysis of murine interferon‐gamma binding to its receptor on intact cells and solubilized membranes. Identification of an 80 kDa receptor. FEBS Lett 242: 233–236. [DOI] [PubMed] [Google Scholar]
  • 12. Corbin JG, Kelly D, Rath EM, Baerwald KD, Suzuki K, Popko B (1996) Targeted CNS expression of interferon‐gamma in transgenic mice leads to hypomyelination, reactive gliosis, and abnormal cerebellar development. Mol Cell Neurosci 7: 354–370. [DOI] [PubMed] [Google Scholar]
  • 13. Deckert‐Schluter M, Bluethmann H, Kaefer N, Rang A, Schluter D (1999) Interferon‐gamma receptor‐mediated but not tumor necrosis factor receptor type 1‐or type 2‐mediated signaling is crucial for the activation of cerebral blood vessel endothelial cells and microglia in murine Toxoplasma encephalitis. Am J Pathol 154: 1549–1561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Deguchi K, Mizuguchi M, Takashima S (1996) Immunohistochemical expression of tumor necrosis factor alpha in neonatal leukomalacia. Pediatr Neurol 14: 13–16. [DOI] [PubMed] [Google Scholar]
  • 15. Follett PL, Rosenberg PA, Volpe JJ, Jensen FE (2000) NBQX attenuates excitotoxic injury in developing white matter. J Neurosci 20: 9235–9241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Hagberg H (2003) No correlation between cerebral palsy and cytokines in postnatal blood of preterms. Pediatr Res 53: 544–545. [DOI] [PubMed] [Google Scholar]
  • 17. Haynes RL, Folkerth RD, Keefe RJ, Sung I, Swzeda LI, Rosenberg PA, Volpe JJ, Kinney HC (2003) Nitrosative and oxidative injury to premyelinating oligodendrocytes in periventricular leukomalacia. J Neuropathol Exp Neurol 62: 441–450. [DOI] [PubMed] [Google Scholar]
  • 18. Heck DE (2001) *NO, RSNO, ONOO‐, NO+, *NOO, NOx‐dynamic regulation of oxidant scavenging, nitric oxide stores, and cyclic GMP‐independent cell signaling. Antioxid Redox Signal 3: 249–260. [DOI] [PubMed] [Google Scholar]
  • 19. Kadhim H, Tabarki B, Verellen G, De Prez C, Rona AM, Sebire G (2001) Inflammatory cytokines in the pathogenesis of periventricular leukomalacia. Neurology 56: 1278–1284. [DOI] [PubMed] [Google Scholar]
  • 20. Kadhim H, Tabarki B, De Prez C, Rona AM, Sebire G (2002) Interleukin‐2 in the pathogenesis of perinatal white matter damage. Neurology 58: 1125–1128. [DOI] [PubMed] [Google Scholar]
  • 21. Kinney H, Armstrong D (1997) Perinatal neuropathology. In: Greenfield's Neuropathology. Graham D and Lantos P (eds). Arnold, London , vol 1, pp 552–555. [Google Scholar]
  • 22. LaFerla FM, Sugarman MC, Lane TE, Leissring MA (2000) Regional hypomyelination and dysplasia in transgenic mice with astrocyte‐directed expression of interferon‐gamma. J Mol Neurosci 15:45–59. [DOI] [PubMed] [Google Scholar]
  • 23. Lee SC, Dickson DW, Liu W, Brosnan CF (1993) Induction of nitric oxide synthase activity in human astrocytes by interleukin‐1 beta and interferon‐gamma. J Neuroimmunol 46: 19–24. [DOI] [PubMed] [Google Scholar]
  • 24. Lee SC, Liu W, Dickson DW, Brosnan CF, Berman JW (1993) Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL‐1 beta. J Immunol 150:2659–2667. [PubMed] [Google Scholar]
  • 25. Ljungdahl A, Olsson T, Van der Meide PH, Holmdahl R, Klareskog L, Hojeberg B (1989) Interferon‐gamma‐like immunoreactivity in certain neurons of the central and peripheral nervous system. J Neurosci Res 24:451–456. [DOI] [PubMed] [Google Scholar]
  • 26. Loscher CE, Donnelly S, Lynch MA, Mills KH (2000) Induction of inflammatory cytokines in the brain following respiratory infection with Bordetella pertussis. J Neuroimmunol 102: 172–181. [DOI] [PubMed] [Google Scholar]
  • 27. Mitrovic B, Ignarro LJ, Vinters HV, Akers MA, Schmid I, Uittenbogaart C, Merrill JE (1995) Nitric oxide induces necrotic but not apoptotic cell death in oligodendrocytes. Neuroscience 65: 531–539. [DOI] [PubMed] [Google Scholar]
  • 28. Moss DW, Bates TE (2001) Activation of murine microglial cell lines by lipopolysaccharide and interferon‐gamma causes NO‐mediated decreases in mitochondrial and cellular function. Eur J Neurosci 13: 529–538. [DOI] [PubMed] [Google Scholar]
  • 29. Munoz‐Fernandez MA, Fresno M (1998) The role of tumour necrosis factor, interleukin 6, interferon‐gamma and inducible nitric oxide synthase in the development and pathology of the nervous system. Prog Neurobiol 56: 307–340. [DOI] [PubMed] [Google Scholar]
  • 30. Naccasha N, Hinson R, Montag A, Ismail M, Bentz L, Mittendorf R (2001) Association between funisitis and elevated interleukin‐6 in cord blood. Obstet Gynecol 97:220–224. [DOI] [PubMed] [Google Scholar]
  • 31. Nelson KB, Grether JK, Dambrosia JM, Walsh E, Kohler S, Satyanarayana G, Nelson PG, Dickens BF, Phillips TM (2003) Neonatal cytokines and cerebral palsy in very preterm infants. Pediatr Res 53: 600–607. [DOI] [PubMed] [Google Scholar]
  • 32. Olsson T (1992) Cytokines in neuroinflammatory disease: role of myelin autoreactive T cell production of interferon‐gamma. J Neuroimmunol 40:211–218. [DOI] [PubMed] [Google Scholar]
  • 33. Popko B, Corbin JG, Baerwald KD, Dupree J, Garcia AM (1997) The effects of interferon‐gamma on the central nervous system. Mol Neurobiol 14:19–35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Pousset F (1994) Cytokines as mediators in the central nervous system. Biomed Pharmacother 48: 425–431. [DOI] [PubMed] [Google Scholar]
  • 35. Rabinovitch A (1992) Free radicals as mediators of pancreatic islet beta‐cell injury in autoimmune diabetes. J Lab Clin Med 119: 455–456. [PubMed] [Google Scholar]
  • 36. Rabinovitch A, Suarez WL, Thomas PD, Strynadka K, Simpson I (1992) Cytotoxic effects of cytokines on rat islets: evidence for involvement of free radicals and lipid peroxidation. Diabetologia 35: 409–413. [DOI] [PubMed] [Google Scholar]
  • 37. Rabinovitch A, Suarez‐Pinzon WL, Strynadka K, Lakey JR, Rajotte RV (1996) Human pancreatic islet beta‐cell destruction by cytokines involves oxygen free radicals and aldehyde production. J Clin Endocrinol Metab 81: 3197–3202. [DOI] [PubMed] [Google Scholar]
  • 38. Rubio N, de Felipe C (1991) Demonstration of the presence of a specific interferon‐gamma receptor on murine astrocyte cell surface. J Neuroimmunol 35:111–117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Schmidt B, Stoll G, Toyka KV, Hartung HP (1990) Rat astrocytes express interferon‐gamma immunoreactivity in normal optic nerve and after nerve transection. Brain Res 515: 347–350. [DOI] [PubMed] [Google Scholar]
  • 40. Takahashi JL, Giuliani F, Power C, Imai Y, Yong VW (2003) Interleukin‐1 beta promotes oligodendrocyte death through glutamate excitotoxicity. Ann Neurol 53: 588–595. [DOI] [PubMed] [Google Scholar]
  • 41. Tedeschi B, Barrett JN, Keane RW (1986) Astrocytes produce interferon that enhances the expression of H‐2 antigens on a subpopulation of brain cells. J Cell Biol 102: 2244–2253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Torres C, Aranguez I, Rubio N (1995) Expression of interferon‐gamma receptors on murine oligodendrocytes and its regulation by cytokines and mitogens. Immunology 86: 250–255. [PMC free article] [PubMed] [Google Scholar]
  • 43. Traugott U, Lebon P (1988) Interferon‐gamma and la antigen are present on astrocytes in active chronic multiple sclerosis lesions. J Neurol Sci 84: 257–264. [DOI] [PubMed] [Google Scholar]
  • 44. Vartanian T, Li Y, Zhao M, Stefansson K (1995) Interferon‐gamma‐induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis. Mol Med 1: 732–743. [PMC free article] [PubMed] [Google Scholar]
  • 45. Vikman KS, Owe‐Larsson B, Brask J, Kristensson KS, Hill RH (2001) Interferon‐gamma‐induced changes in synaptic activity and AMPA receptor clustering in hippocampal cultures. Brain Res 896:18–29. [DOI] [PubMed] [Google Scholar]
  • 46. Volpe J (2001) Neurology of the Newborn, Philadelphia .
  • 47. Volpe JJ (2001) Neurobiology of periventricular leukomalacia in the premature infant. Pediatr Res 50: 553–562. [DOI] [PubMed] [Google Scholar]
  • 48. Wu YW, Colford JM, Jr. (2000) Chorioamnionitis as a risk factor for cerebral palsy: A metaanalysis. JAMA 284: 1417–1424. [DOI] [PubMed] [Google Scholar]
  • 49. Wu YW (2002) Systematic review of chorioamnionitis and cerebral palsy. Ment Retard Dev Disabil Res Rev 8: 25–29. [DOI] [PubMed] [Google Scholar]
  • 50. Yong VW, Moumdjian R, Yong FP, Ruijs TC, Freedman MS, Cashman N, Antel JP (1991) Gamma‐interferon promotes proliferation of adult human astrocytes in vitro and reactive gliosis in the adult mouse brain in vivo. Proc Natl Acad Sci USA 88: 7016–7020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Yong VW, Tejada‐Berges T, Goodyer CG, Antel JP, Yong FP (1992) Differential proliferative response of human and mouse astrocytes to gamma‐interferon. Glia 6: 269–280. [DOI] [PubMed] [Google Scholar]
  • 52. Yoon BH, Romero R, Kim CJ, Koo JN, Choe G, Syn HC, Chi JG (1997) High expression of tumor necrosis factor‐alpha and interleukin‐6 in periventricular leukomalacia. Am J Obstet Gynecol 177:406–411. [DOI] [PubMed] [Google Scholar]

Articles from Brain Pathology are provided here courtesy of Wiley

RESOURCES